A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials”.
Saved in:
| Title: | A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials”. |
|---|---|
| Authors: | Friedman, Scott M.1 (AUTHOR) smfriedman83@hotmail.com, Xu, Yingxin2 (AUTHOR), Sherman, Steven2 (AUTHOR), Kuznik, Andreas2 (AUTHOR), Mojebi, Ali3 (AUTHOR), Keeping, Sam3 (AUTHOR), Chan, Keith3 (AUTHOR), Leng, Theodore4 (AUTHOR), Patel, Nimesh5,6 (AUTHOR) |
| Source: | Ophthalmology & Therapy. Jul2026, p1-4. 4p. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 195217056 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials”. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Friedman%2C+Scott+M%2E%22">Friedman, Scott M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> smfriedman83@hotmail.com</i><br /><searchLink fieldCode="AR" term="%22Xu%2C+Yingxin%22">Xu, Yingxin</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sherman%2C+Steven%22">Sherman, Steven</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kuznik%2C+Andreas%22">Kuznik, Andreas</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mojebi%2C+Ali%22">Mojebi, Ali</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Keeping%2C+Sam%22">Keeping, Sam</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chan%2C+Keith%22">Chan, Keith</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Leng%2C+Theodore%22">Leng, Theodore</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Patel%2C+Nimesh%22">Patel, Nimesh</searchLink><relatesTo>5,6</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Ophthalmology+%26+Therapy%22">Ophthalmology & Therapy</searchLink>. Jul2026, p1-4. 4p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=195217056 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40123-026-01439-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 4 StartPage: 1 Titles: – TitleFull: A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials”. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Friedman, Scott M. – PersonEntity: Name: NameFull: Xu, Yingxin – PersonEntity: Name: NameFull: Sherman, Steven – PersonEntity: Name: NameFull: Kuznik, Andreas – PersonEntity: Name: NameFull: Mojebi, Ali – PersonEntity: Name: NameFull: Keeping, Sam – PersonEntity: Name: NameFull: Chan, Keith – PersonEntity: Name: NameFull: Leng, Theodore – PersonEntity: Name: NameFull: Patel, Nimesh IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 07 Text: Jul2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 21938245 Titles: – TitleFull: Ophthalmology & Therapy Type: main |
| ResultId | 1 |
